{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T23:42:41Z","timestamp":1776987761030,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-026-26979-0","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:04:19Z","timestamp":1773705859000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Whole genome sequencing for Mycobacterium tuberculosis in public health responses: a review of current practice and enablers in select low-incidence jurisdictions"],"prefix":"10.1186","volume":"26","author":[{"given":"Justin T.","family":"Denholm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Anthony","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthijs","family":"Backx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian F.","family":"Laurenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amie-Louise","family":"Seagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Trieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herns","family":"Modestil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanne Sullivan","family":"Meissner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah Hee Ling","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun Yang","family":"Tay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben J.","family":"Marais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitali","family":"Sintchenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robyn","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen J.","family":"Donnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"26979_CR1","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1016\/j.ijid.2021.02.114","volume":"113","author":"AK Gordon","year":"2021","unstructured":"Gordon AK, Marais B, Walker TM, Sintchenko V. Clinical and public health utility of Mycobacterium tuberculosis whole genome sequencing. Int J Infect Dis. 2021;113:S40\u20132.","journal-title":"Int J Infect Dis"},{"issue":"10","key":"26979_CR2","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S2213-2600(13)70231-5","volume":"1","author":"JM Bryant","year":"2013","unstructured":"Bryant JM, Harris SR, Parkhill J, et al. Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study. Lancet Respiratory Medicine. 2013;1(10):786\u201392.","journal-title":"Lancet Respiratory Medicine"},{"key":"26979_CR3","doi-asserted-by":"publisher","unstructured":"Donnan EJ, Marais BJ, Coulter C, et al. The use of whole genome sequencing for tuberculosis public health activities in Australia: a joint statement of the National Tuberculosis Advisory Committee and Communicable Diseases Genomics Network. Communicable Dis Intell. 2023;47. https:\/\/doi.org\/10.33321\/cdi.2023.47.8.","DOI":"10.33321\/cdi.2023.47.8"},{"issue":"1","key":"26979_CR4","doi-asserted-by":"publisher","first-page":"15333","DOI":"10.1038\/s41598-021-94297-z","volume":"11","author":"M Vogel","year":"2021","unstructured":"Vogel M, Utpatel C, Corbett C, et al. Implementation of whole genome sequencing for tuberculosis diagnostics in a low-middle income, high MDR-TB burden country. Sci Rep. 2021;11(1):15333.","journal-title":"Sci Rep"},{"issue":"4","key":"26979_CR5","doi-asserted-by":"publisher","first-page":"bbaa246","DOI":"10.1093\/bib\/bbaa246","volume":"22","author":"E Rivi\u00e8re","year":"2021","unstructured":"Rivi\u00e8re E, Heupink TH, Ismail N, et al. Capacity building for whole genome sequencing of Mycobacterium tuberculosis and bioinformatics in high TB burden countries. Brief Bioinform. 2021;22(4):bbaa246.","journal-title":"Brief Bioinform"},{"key":"26979_CR6","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41579-019-0214-5","volume":"17","author":"CJ Meehan","year":"2019","unstructured":"Meehan CJ, Goig GA, Kohl TA, et al. Whole genome sequencing of Mycobacterium tuberculosis: Current standards and open issues. Nature Rev Microbiol. 2019;17:533\u201345.","journal-title":"Nature Rev Microbiol"},{"issue":"4","key":"26979_CR7","doi-asserted-by":"publisher","first-page":"e265","DOI":"10.1016\/S2666-5247(21)00301-3","volume":"3","author":"TM Walker","year":"2021","unstructured":"Walker TM, Miotto P, K\u00f6ser CU, et al. The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: A new global standard for molecular diagnostics. Lancet Microbe. 2021;3(4):e265\u201373.","journal-title":"Lancet Microbe"},{"issue":"15","key":"26979_CR8","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1056\/NEJMoa1800474","volume":"379","author":"CRyPTIC Consortium and the 100,000 Genomes Project","year":"2018","unstructured":"CRyPTIC Consortium and the 100,000 Genomes Project. Prediction of susceptibility to first-line tuberculosis drugs by DNA sequencing. N Engl J Med. 2018;379(15):1403\u201315.","journal-title":"N Engl J Med"},{"issue":"10","key":"26979_CR9","doi-asserted-by":"publisher","first-page":"431","DOI":"10.5588\/ijtldopen.24.0320","volume":"1","author":"JT Denholm","year":"2024","unstructured":"Denholm JT, de Vries G, Anthony R, et al. Considering best practice standards for routine whole-genome sequencing for TB care and control. IJTLD Open. 2024;1(10):431\u20136.","journal-title":"IJTLD Open"},{"issue":"1","key":"26979_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S2213-2600(15)00466-X","volume":"4","author":"LJ Pankhurst","year":"2016","unstructured":"Pankhurst LJ, del Ojo EC, Votintseva AA, et al. Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study. Lancet Resp Med. 2016;4(1):49\u201358.","journal-title":"Lancet Resp Med"},{"key":"26979_CR11","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.15603.1","volume":"4","author":"M Hunt","year":"2019","unstructured":"Hunt M, Bradley P, Lapierre SG, et al. Antibiotic resistance prediction for Mycobacterium tuberculosis from genome sequence data with Mykrobe. Wellcome Open Res. 2019;4:191. https:\/\/doi.org\/10.12688\/wellcomeopenres.15603.1.","journal-title":"Wellcome Open Res"},{"issue":"1","key":"26979_CR12","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02244-22","volume":"11","author":"RM Anthony","year":"2023","unstructured":"Anthony RM, Tagliani E, Nikolayevskyy V, et al. Experiences from 4 years of organization of an external quality assessment for Mycobacterium tuberculosis whole-genome sequencing in the European Union\/European Economic Area. Microbiol Spectr. 2023;11(1):e0224422. https:\/\/doi.org\/10.1128\/spectrum.02244-22.","journal-title":"Microbiol Spectr"},{"key":"26979_CR13","unstructured":"Tuberculosis in England. UK Health Security Agency. .2022. Available at https:\/\/www.gov.uk\/government\/publications\/tuberculosis-in-england-2022-report-data-up-to-end-of-2021.\u00a0Accessed 23 Dec 2023."},{"issue":"6","key":"26979_CR14","doi-asserted-by":"publisher","first-page":"471","DOI":"10.5588\/ijtld.22.0676","volume":"27","author":"G de Vries","year":"2023","unstructured":"de Vries G, Akkerman O, Boeree M, et al. Diagnosis, treatment and transmission of rifampicin-resistant TB in the Netherlands, 2010\u20132019. Int J Tuberc Lung Dis. 2023;27(6):471\u20137.","journal-title":"Int J Tuberc Lung Dis"},{"key":"26979_CR15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ijid.2017.12.010","volume":"67","author":"ZJM Ho","year":"2018","unstructured":"Ho ZJM, Chee CBE, Ong RT, et al. Investigation of a cluster of multi-drug resistant tuberculosis in a high-rise apartment block in Singapore. Int J Infect Dis. 2018;67:46\u201351. https:\/\/doi.org\/10.1016\/j.ijid.2017.12.010.","journal-title":"Int J Infect Dis"},{"key":"26979_CR16","doi-asserted-by":"publisher","unstructured":"Wyllie DH, Sanderson N, Myers R et al. Control of artefactual variation in reported inter-sample relatedness during clinical use of a sequencing pipeline. J Clinical Microbiol, 2018;56(8). https:\/\/doi.org\/10.1128\/jcm.00104-18.","DOI":"10.1128\/jcm.00104-18"},{"key":"26979_CR17","unstructured":"Mycobacterium tuberculosis whole genome sequencing and cluster investigation handbook. London:UKHSA; 2021. Available from https:\/\/www.gov.uk\/government\/publications\/tb-strain-typing-and-cluster-investigation-handbook\/mycobacterium-tuberculosis-whole-genome-sequencing-and-cluster-investigation-handbook."},{"key":"26979_CR18","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00298-17","author":"J Shea","year":"2017","unstructured":"Shea J, Halse TA, Lapierre P, et al. Comprehensive whole-genome sequencing and reporting of drug resistance profiles on clinical cases of Mycobacterium tuberculosis in New York State. J Clin Microbiol. 2017. https:\/\/doi.org\/10.1128\/jcm.00298-17.","journal-title":"J Clin Microbiol"},{"key":"26979_CR19","unstructured":"Centers for disease control and prevention. Launch of TB Genotyping Information Management System (TB GIMS). MMWR Morb Mortal Wkly Rep. 2010;59(10):300."},{"key":"26979_CR20","unstructured":"New York City Department of Health and Mental Hygiene. Bureau of Tuberculosis Control Annual Summary, 2022. Long Island City, NY. 2023. Available from https:\/\/www.nyc.gov\/assets\/doh\/downloads\/pdf\/tb\/tuberculosis-in-new-york-city-2022-annual-report.pdf."},{"key":"26979_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2022.100556","volume":"28","author":"K Dale","year":"2022","unstructured":"Dale K, Globan M, Horan K, et al. Whole genome sequencing for tuberculosis in Victoria, Australia: A genomic implementation study from 2017 to 2020. The Lancet Regional Health-Western Pacific. 2022;28:100556.","journal-title":"The Lancet Regional Health-Western Pacific"},{"issue":"1","key":"26979_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13073-021-00934-7","volume":"13","author":"AS Ferdinand","year":"2021","unstructured":"Ferdinand AS, Kelaher M, Lane CR, et al. An implementation science approach to evaluating pathogen whole genome sequencing in public health. Genome Medicine. 2021;13(1):121.","journal-title":"Genome Medicine"},{"issue":"3","key":"26979_CR23","doi-asserted-by":"publisher","first-page":"241","DOI":"10.5588\/ijtld.20.0740","volume":"25","author":"SY Tong","year":"2021","unstructured":"Tong SY, Martinez E, Crighton T, Denholm JT, Sintchenko V. TB genomic surveillance and data sharing in recognising contamination events. Int J TB Lung Dis. 2021;25(3):241\u20133.","journal-title":"Int J TB Lung Dis"},{"key":"26979_CR24","doi-asserted-by":"crossref","unstructured":"Zhang X, Martinez E, Lam C, et al. Exploring programmatic indicators for tuberculosis control that incorporate routine Mycobacterium tuberculosis sequencing in a low incidence setting: A comprehensive (2017\u20132021) patient cohort analysis. The Lancet Regional Health \u2013 Western Pacific. 2023; 41:100910.","DOI":"10.1016\/j.lanwpc.2023.100910"},{"key":"26979_CR25","unstructured":"AusTRAKKA Real-time pathogen genomic surveillance. Communicable Diseases Genomics Network Australia. Melbourne, 2022. Available from https:\/\/www.cdgn.org.au\/austrakka."},{"issue":"1","key":"26979_CR26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12879-018-3164-z","volume":"18","author":"L Parvaresh","year":"2018","unstructured":"Parvaresh L, Crighton C, Martinez E, Bustamante A, Chen SCA, Sintchenko V. Recurrence of tuberculosis in a low-incidence setting: a retrospective cross-sectional study augmented by whole genome sequencing. BMC Infect Dis. 2018;18(1):265. https:\/\/doi.org\/10.1186\/s12879-018-3164-z.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"26979_CR27","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1128\/JCM.02993-14","volume":"53","author":"AA Witney","year":"2015","unstructured":"Witney AA, Gould KA, Arnold A, et al. Clinical application of whole-genome sequencing to inform treatment for multidrug-resistant tuberculosis cases. J Clin Microbiol. 2015;53(5):1473\u201383.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"26979_CR28","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1136\/thoraxjnl-2019-214004","volume":"76","author":"T Mugwagwa","year":"2021","unstructured":"Mugwagwa T, Abubakar I, White PJ. Using molecular testing and whole-genome sequencing for tuberculosis diagnosis in a low-burden setting: a cost-effectiveness analysis using transmission-dynamic modelling. Thorax. 2021;76(3):281\u201391.","journal-title":"Thorax"},{"issue":"7","key":"26979_CR29","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1017\/S095026881800047X","volume":"146","author":"O Popovici","year":"2018","unstructured":"Popovici O, Monk P, Chemtob D, et al. Cross-border outbreak of extensively drug-resistant tuberculosis linked to a university in Romania. Epidemiol Infect. 2018;146(7):824\u201331.","journal-title":"Epidemiol Infect"},{"issue":"11","key":"26979_CR30","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00923-18","volume":"56","author":"DH Wyllie","year":"2018","unstructured":"Wyllie DH, Robinson E, Peto T, et al. Identifying mixed Mycobacterium tuberculosis infection and laboratory cross-contamination during mycobacterial sequencing programs. J Clin Microbiol. 2018;56(11):e00923-18. https:\/\/doi.org\/10.1128\/JCM.00923-18.","journal-title":"J Clin Microbiol"},{"issue":"12","key":"26979_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2023.100443","volume":"3","author":"P Pronyk","year":"2023","unstructured":"Pronyk P, de Adamberage Alwis R, et al. Advancing pathogen genomics in resource-limited settings. Cell Genom. 2023;3(12):100443. https:\/\/doi.org\/10.1016\/j.xgen.2023.100443.","journal-title":"Cell Genom"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-26979-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-26979-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-26979-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T23:17:33Z","timestamp":1776986253000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-26979-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["26979"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-26979-0","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"21 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No individual patient was accessed for this report, and no participants were enrolled for this policy and practice review. Under the National Statement on the Ethical Conduct in Human Research 2023 (National Health and Medical Research Council Australia) this project was of minimal risk (5.1.10) and thereby exempt from ethics committee review or requirement for consent. Use of programmatic data was approved by the Melbourne Health Human Research Ethics Committee (MH 2022.179), with waiver of consent granted.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1341"}}